Stem cell transplantation in brain tumors: A new field for molecular imaging?

Molecular Medicine

Volumn 16, Issue 9-10, 2010, Pages 433-437

  Sandu, Nora ^a   Schaller, Bernhard ^b  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b Universite Paris 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

BLOOD BRAIN BARRIER; BRAIN TUMOR; CELL HYPOXIA; CELL MIGRATION; GENE EXPRESSION; GENETIC ENGINEERING; HUMAN; IMMUNOMODULATION; MOLECULAR IMAGING; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR CELL; TUMOR MICROENVIRONMENT;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; HUMANS; MOLECULAR IMAGING; NEURAL STEM CELLS; STEM CELL TRANSPLANTATION; TUMOR MICROENVIRONMENT;

EID: 77956644712     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2010.00035     Document Type: Review

References (59)

1. Yip S, et al. (2003) Neural stem cell biology may be well suited for improving brain-tumor therapies. Cancer. J. 9:189-204.
2. Thu MS, et al. (2009) Iron labelling and preclinical MRI visualization of therapeutic human neural stem cell in a murine gliome model. PLoSOne. 4:e7218.
3. Schaller B. (2003) Neuroprotection in brain tumors: good sense or nonsense from the pathophysiological viewpoint? Nervenarzt. 74:134-6.
4. Schaller BJ, Buchfelder M. (2006) Neuroprotection in primary brain tumors: sense or nonsense? Expert Rev. Neurother. 6:723-30.
5. Schaller BJ, Cornelius JF, Sandu N, Buchfelder M. (2008) Molecular imaging of brain tumors: Personal experience and review of the literature. Curr. Mol. Med. 8:711-26.
6. Schaller B, Cornelius JF, Sandu N. (2008) Molecular medicine successes in neuroscience. Mol. Med. 14:361-4.
7. Kosztowski T, Zaidi HA, Quinones-Hinojasa A. (2009) Application of neural and mesenchymal stem cells in the treatment of gliomas. Expert Rev. Anticancer Ther. 9:597-612.
8. Schaller B. (2005) Influences of brain tumor-associated pH changes and hypoxia on epileptogenesis. Acta Neurol. Scand. 111:75-83.
9. Zhao P, et al. (2008) Neural stem cell tropism to glioma: critical role of tumor hypoxia. Mol. Cancer Res. 6:1819-29.
10. Matuski E, et al. (2009) Cell adhesion markers in ischaemic stroke patients: correlation with clinical outcome and comparison with primary autoimmune disease. Arch. Med. Sci. 5:182-9.
11. Schaller BJ. (2006) The role of endothelin in stroke: experimental data and underlying pathophysiology. Arch. Med. Sci. 2:146-58.
12. Schaller B. (2005) Ischemic preconditioning as induction of ischemic tolerance after transient ischemic attacks in human brain: its clinical relevance. Neurosci. Let. 377:206-11.
13. Oliver L, Olivier C, Marhuenda FB, Campone M, Vallette FM. (2009) Hypoxia and the malignant glioma microenvironment: regulation and implications for therapy. Curr. Mol. Pharmacol. 2:263-84.
14. Schaller B, Graf R. (2004) Cerebral ischemia and reperfusion: the pathophysiologic concept as a basis for clinical therapy. J. Cereb. Blood Flow Metab. 24:351-71.
15. Schaller BJ, Modo M, Buchfelder M. (2007) Molecular imaging of brain tumors: A bridge between clinical and molecular medicine? Mol. Imaging Biol. 9:60-71.
16. Schaller B, Cornelius JF, Sandu N, Ottaviani G, Perez-Pinzon MA. (2009) Oxygen-conserving reflexes of the brain: the current molecular knowledge. J. Cell Mol. Med. 13:644-7.
17. Aboody K, et al. (2000) Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intra cranial gliomas. Proc. Natl. Acad. Sci. U. S. A. 97:12846-51.
18. Benedetti S, et al. (2000) Gene therapy of experimental brain tumors using neural progenitor cells. Nat. Med. 6:447-50.
19. Schmidt NO, et al. (2005) Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor. Neoplasia. 7:623-9.
20. Staflin K, et al. (2004) Neural progenitor cell lines rat inhibit tumor growth in vivo. Cancer Res. 64:5347-54.
21. Ethesham M, et al. (2002) The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma. Cancer Res. 62:5657-63.
22. Fomchenko EI, Holland EC. (2005) Stem cells and brain cancer. Exp. Cell Res. 306:323-9.
23. Modo M, Roberts TJ, Sandhu JK, Williams SCR. (2004) In vivo monitoring of cellular transplants by magnetic resonance imaging and positron emission tomography. Expert Opin. Bio. Ther. 4:145-55.
24. Zlokovic BV, Apuzzo ML. (1997) Cellular and molecular neurosurgery: Pathways from concept to reality, part 1: target disorders and concept approaches to gene therapy of the central nervous system. Neurosurgery. 40:789-803.
25. Marchi N, et al. (2010) Multimodal investigations of trans-endothelial cell trafficking under condition of disrupted blood-brain barrier integrity. BMC Neurosci. 9:11-34.
26. Gera A, Steinberg GK, Guzman R. (2010) In vivo neural stem cell imaging: Current modalities and future directions. Regen. Med. 5:73-86.
27. Rapoport SI, Hori M, Klatzo I. (1972) Testing of a hypothesis for osmotic opening of the bloodbrain barrier. Am. J. Physiol. 223:323-31.
28. Kurozumi K, et al. (2007) Effect of tumor microenvironment modulation on the efficacy of oncolytic virus therapy. J. Natl. Cancer Inst. 99:1768-81.
29. Bradbury MS, et al. (2007) Optical bioluminescence imaging of human ES cell progeny in the rodent CNS. J. Neurochem. 102:2029-39.
30. Wilson K, Yu J, Lee A, Wu JC. (2008) In vitro and in vivo bioluminescence reporter gene imaging of human embryonic stem cells. J. Vis. Exp. (14):740.
31. Narsinh KH, Cao F, Wu JC. (2009) Molecular imaging of human embryonic stem cells. Methods Mol. Biol. 515:13-32.
32. Jacobs AH, et al. (2003) PET-based molecular imaging in neuroscience. Eur. J. Nucl. Med. Mol. Imaging. 30:1051-65.
33. Thu MS, et al. (2009) Iron labeling and preclinical MRI visualization of therapeutic human neural stem cells in a murine glioma model. PLoS. 4:e7218.
34. Modo M, et al. (2002) Tracking transplanted stem cell migration using bifunctional, contrast agentenhanced, magnetic resonance imaging. Neuroimage. 17:803-11.
35. Modo M, et al. (2004) Mapping transplanted stem cell migration after a stroke: a serial, in vivo magnetic resonance imaging study. Neuroimage. 21:311-7.
36. Corot C, Robert P, Idee JM, Port M. (2006) Recent advances in iron oxide nanocrystal technology for medical imaging. Adv. Drug Deliv. Rev. 58:1471-504.
37. Modo M, Hoehn M, Bulte J. (2005) Cellular MR imaging. Mol. Imaging. 4:1Y21.
38. Schaller BJ. (2008) Strategies for molecular imaging dementia and neurodegenerative diseases. Neuropsychiatr. Dis. Treat. 4:585-612.
39. Chin BB, et al. (2003) 111In oxine labeled mesenchymal stem cell SPECT after intravenous administration in myocardial infarction. Nucl. Med. Commun. 24:1149-54.
40. Jacobs A, et al. (2001) Quantitative kinetics of (124I)FIAU in cat and man. J. Nucl. Med. 42:467-75.
41. Pauwels EK, et al. (1998) FDG accumulation and tumor biology. Nucl. Med. Biol. 25:317-22.
42. Weber WA, Schwaiger M, Avril N. (2007) Quantitative assessment of tumor metabolism using FDG-PET imaging. Nucl. Med. Biol. 27:683-7.
43. Schaller B. (2004) Usefulness of positron emission tomography in diagnosis and treatment followup of brain tumors. Neurobiol. Dis. 15:437-48.
44. Shah K, Hsich G, Breakefield XO. (2004) Neural precursor cells and their role in neuro-oncology. Dev. Neurosci. 26:118-30.
45. Koehne G, et al. (2003) Serial in vivo imaging of targeted migration of human HSV-TK-transduced antigen-specific lymphocytes. Nat. Biotechnol. 21:405-13.
46. Filmont JE, et al. (2003) Value of F-18 fluorodeoxyglucose positron emission tomography for predicting the clinical outcome of patients with aggressive lymphoma prior to and after autologous stem-cell transplantation. Chest. 124:608-13.
47. Becherer A, et al. (2002) Positron emission tomography with [18F]2- fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation. Leukemia. 16:260-7.
48. Spaepen K, et al. (2003) Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with highdose chemotherapy and stem cell transplantation. Blood. 102:53-9.
49. Cremerius U, et al. (2002) Pre-transplant positron emission tomography (PET) using fluorine-18- fluoro-deoxyglucose (FDG) predicts outcome in patients treated with high-dose chemotherapy and autologous stem cell transplantation for non- Hodgkins lymphoma. Bone Marrow Transplant. 30:103-11.
50. Su H, Forbes A, Gamghir SS, Braun J. (2004) Quantization of cell number by a positron emission tomography reporter gene strategy. Mol. Imaging Biol. 6:139-48.
51. Brower V. (2005) Search and destroy: recent research exploits adult stem cells' attraction to cancer. J. Natl. Cancer Inst. 97:414-6.
52. De Witte O, et al. (2000) FDG-PET as a prognostic factor in high-grade astrocytoma. J. Neurooncol. 49:157-63.
53. Padma MV, et al. (2003) Prediction of pathology and survival by FDG PET in gliomas. J. Neurooncol. 64:227-37.
54. Shah K, et al. (2008) Biomodal viral vectors and in vivo imaging reveal the fate of human neural stem cells in experimental glioma model. J. Neurosci. 28:4406-13.
55. Brekke C, et al. (2007) Cellular multiparametric MRI of neural stem cell therapy in a rat glioma model. Neuroimage. 37:769-82.
56. Anderson SA, et al. (2005) Noninvasive MR imaging of magnetically labelled stem cells to directly identify neovasculature in a glioma model. Blood. 105:420-5.
57. Hata N, et al. (2010) Platelet-derived growth factor BB mediates the tropism of human mesenchymal stem cells for malignant gliomas. Neurosurgery. 66:144-56.
58. Miletic H, et al. (2007) Bystander killing of malignant glioma by bone marrow-derived tumor-infiltrating progenitor cells expressing a suicide gene. Mol. Ther. 15:1373-81.
59. Shah K, Weissleder R. (2005) Molecular optical imaging: applications leading to the development of present day therapeutics. NeuroRx. 2:215-25.